Skip to main content
Literatur
1.
Zurück zum Zitat Cetinel B, Onal B, Gultekin MH, Guzelsoy M, Turegun FA, Dincer M (2019) Which antimuscarinic agents used in the treatment of overactive bladder increase heart rate? a prospective randomized clinical trial. Int Urol Nephrol 51(3):417–424CrossRef Cetinel B, Onal B, Gultekin MH, Guzelsoy M, Turegun FA, Dincer M (2019) Which antimuscarinic agents used in the treatment of overactive bladder increase heart rate? a prospective randomized clinical trial. Int Urol Nephrol 51(3):417–424CrossRef
2.
Zurück zum Zitat Severinghaus JW (2007) Takuo Aoyagi: discovery of pulse oximetry. Anesth Analg 105(6 Suppl):S1–S4CrossRef Severinghaus JW (2007) Takuo Aoyagi: discovery of pulse oximetry. Anesth Analg 105(6 Suppl):S1–S4CrossRef
3.
Zurück zum Zitat Yetkin U, Karahan N, Gürbüz A (2002) Klinik Uygulamada Pulse Oksimetre. Van Tıp Dergisi 9(4):126–133 (Article in Turkish) Yetkin U, Karahan N, Gürbüz A (2002) Klinik Uygulamada Pulse Oksimetre. Van Tıp Dergisi 9(4):126–133 (Article in Turkish)
4.
Zurück zum Zitat Ristikankare M, Karinen-Mantila H (2016) The role of routinely given hyoscine-N-butylbromide in colonoscopy: a double-blind, randomized, placebo-controlled, clinical trial. Scand J Gastroenterol 51(3):368–373CrossRef Ristikankare M, Karinen-Mantila H (2016) The role of routinely given hyoscine-N-butylbromide in colonoscopy: a double-blind, randomized, placebo-controlled, clinical trial. Scand J Gastroenterol 51(3):368–373CrossRef
5.
Zurück zum Zitat Kossmann CE (1953) The normal electrocardiogram. Circulation 8:920–936CrossRef Kossmann CE (1953) The normal electrocardiogram. Circulation 8:920–936CrossRef
6.
Zurück zum Zitat Andersson KE, Sarawate C, Kahler KH, Stanley EL, Kulkarni AS (2010) Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder. BJU Int 106(2):268–274CrossRef Andersson KE, Sarawate C, Kahler KH, Stanley EL, Kulkarni AS (2010) Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder. BJU Int 106(2):268–274CrossRef
7.
Zurück zum Zitat Rothman KJ (2010) Curbing type I and type II errors. Eur J Epidemiol 25(4):223–224CrossRef Rothman KJ (2010) Curbing type I and type II errors. Eur J Epidemiol 25(4):223–224CrossRef
8.
Zurück zum Zitat Tadic M, Cuspidi C, Grassi G (2018) Heart rate as a predictor of cardiovascular risk. Eur J Clin Invest 48:e12892CrossRef Tadic M, Cuspidi C, Grassi G (2018) Heart rate as a predictor of cardiovascular risk. Eur J Clin Invest 48:e12892CrossRef
9.
Zurück zum Zitat Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Authors/Task Force Members; Document Reviewers et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18(8):891–975CrossRef Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Authors/Task Force Members; Document Reviewers et al (2016) 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18(8):891–975CrossRef
10.
Zurück zum Zitat Asche CV, Kim J, Kulkarni AS, Chakravarti P, Andersson KE (2012) Presence of central nervous system, cardiovascular and overall co-morbidity burden in patients with overactive bladder disorder in a real-world setting. BJU Int 109(4):572–580CrossRef Asche CV, Kim J, Kulkarni AS, Chakravarti P, Andersson KE (2012) Presence of central nervous system, cardiovascular and overall co-morbidity burden in patients with overactive bladder disorder in a real-world setting. BJU Int 109(4):572–580CrossRef
Metadaten
Titel
Re: Letter to editor: heart rate effects of antimuscarinic drugs
verfasst von
Bulent Cetinel
Bulent Onal
Mehmet Hamza Gultekin
Publikationsdatum
27.07.2019
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 10/2019
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-019-02240-z

Weitere Artikel der Ausgabe 10/2019

International Urology and Nephrology 10/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.